Literature DB >> 17238816

Efficiency of instillation methods for prostaglandin medications.

Richard Fiscella1, Jacob T Wilensky, Tina H Chiang, John G Walt.   

Abstract

PURPOSE: The aim of this study was to determine the most efficient methods for instillation of prostaglandin analogs.
METHODS: Drops were dispensed at room temperature from 2.5-mL bottles of bimatoprost, travoprost, and latanoprost. Two determinations of drop count were each made from bottles held vertically, at a 45-degree angle, and horizontally. The total volumes of medication dispensed from each bottle were measured.
RESULTS: The mean number of drops dispensed was 111.0, 105.1, and 76.1 drops for bimatoprost bottles; 81.4, 101.1, and 85.3 drops for travoprost bottles; and 94.3, 88.4, and 67.1 drops for latanoprost bottles, held vertically, at 45 degrees, and horizontally, respectively. The mean volume of medication dispensed per 2.5-mL bottle was 3.17 mL for bimatoprost, 2.54 mL for travoprost, and 3.02 mL for latanoprost. The most efficient instillation methods provided 56 days of bilateral therapy per 2.5-mL bottle for bimatoprost, 51 days for travoprost, and 47 days for latanoprost, with corresponding yearly medication costs of $408 for bimatoprost, $449 for travoprost, and $475 for latanoprost. Yearly savings of $109 to $192 could be achieved by using the most efficient instillation methods, representing 5.6 months of medication saved for patients using bimatoprost, 3.0 months for patients using travoprost, and 4.9 months for patients using latanoprost.
CONCLUSIONS: Health care providers are urged to instruct glaucoma patients in the most efficient method of instillation. For bimatoprost and latanoprost, vertical instillation is recommended, with 45 degrees nearly as efficient, and for travoprost, instillation at 45 degrees is recommended.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17238816     DOI: 10.1089/jop.2006.22.477

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  6 in total

1.  Variation in Number of Doses, Bottle Volume, and Calculated Yearly Cost of Generic and Branded Latanoprost for Glaucoma.

Authors:  Joanna H Queen; Robert M Feldman; David A Lee
Journal:  Am J Ophthalmol       Date:  2015-11-18       Impact factor: 5.258

2.  Refill rates and budget impact of glaucoma lipid therapy: a retrospective database analysis.

Authors:  John G Walt; Jacob T Wilensky; Richard Fiscella; Tina H Chiang; Angela Guckian
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

3.  Bottle Characteristics of Topical International Glaucoma Medications versus Local Brands in Saudi Arabia.

Authors:  Nasser Al-Jumaian; Rizwan Malik; Rajiv Khandekar; Abdullah Al-Humaidan; Rana Al-Madany; Reham Al-Qahtani; Ahmed Altowairqi; Abdulwahab Al-Theeb; Babar Zaman; Leyla Al-Djasim; E Randy Craven; Deepak P Edward
Journal:  Middle East Afr J Ophthalmol       Date:  2016 Oct-Dec

4.  An objective assessment of the variability in number of drops per bottle of glaucoma medication.

Authors:  Daniel B Moore; Judy Beck; Richard J Kryscio
Journal:  BMC Ophthalmol       Date:  2017-05-22       Impact factor: 2.209

5.  Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension.

Authors:  Ronald E P Frenkel; Max Frenkel; Allison Toler
Journal:  BMC Ophthalmol       Date:  2007-09-27       Impact factor: 2.209

6.  Comparative study of the stability of bimatoprost 0.03% and latanoprost 0.005%: a patient-use study.

Authors:  Mauricio D Paolera; Niro Kasahara; Cristiano C Umbelino; John G Walt
Journal:  BMC Ophthalmol       Date:  2008-06-11       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.